Tomorrow, 4,865,500 Doses Of Covovax Vaccine Land In Indonesia

JAKARTA - The Indonesian Consulate General in Mumbai assisted in assisting and escorting the delivery of the Covovax COVID-19 vaccine made by the Serum Institute India (SII) to Indonesia, Wednesday local time.

"The number of Covovax vaccines in phase II delivery is 4,865,500 doses to complete the total commitment of five million doses that has been finalized between the Serum Institute India entity and Indofarma," said the Indonesian Consulate General in Mumbai in a written statement, Antara, Wednesday, December 1.

Millions of doses of the vaccine were flown from Chattrapaji Shivaji Airport, Mumbai, to Indonesia via Dubai and are expected to arrive in Indonesia on December 2, 2021.

Previously, on November 26, 2021, the first phase of Covovax vaccine was shipped from India to the country as many as 134,500 doses.

Covovax vaccine is a recombinant spike protein vaccine produced by SII that has been registered to meet vaccination needs as part of preventive efforts in the strategy for handling the COVID-19 pandemic.

The commitment to fulfill the Covovax vaccine was made between SII, one of the largest vaccine producers in the world, and Indofarma, an Indonesian pharmaceutical state-owned company.

"As a form of support in the national effort to handle the COVID-19 pandemic in Indonesia as well as to achieve the goal of herd immunity through the national vaccination program in Indonesia, the Indonesian Consulate General in Mumbai has carried out various simultaneous efforts, particularly efforts in terms of assistance and facilitation of the delivery of medicinal raw materials needed in handling COVID-19 and the COVID-19 vaccine since the beginning of the pandemic have spread in the country," the Indonesian Consulate General said in a statement.